| 2025-11-13 |
详情>>
股本变动：
变动后总股本857.07万股
|
| 2025-11-13 |
详情>>
业绩披露：
2026年一季报每股收益-0.02美元,归母净利润-20.1万美元,同比去年增长89.75%
|
| 2025-09-26 |
详情>>
业绩披露：
2025年年报每股收益-0.77美元,归母净利润-508.57万美元,同比去年增长55.30%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.79美元,归母净利润-488.13万美元,同比去年增长18.60%
|
| 2025-03-28 |
股东大会：
将于2025-05-07召开股东大会
会议内容 ▼▲
- 1.To elect the Board’s nominees, Yijin Chen, Zhixin Liu, Fu Liu, Yan Yang, and Chun Kwok Wong, each to serve as a director of the Company until the next annual meeting of stockholders or until their respective successors shall have been elected and qualified;
2.To ratify the appointment of Kreit & Chiu CPA LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025;
3.To approve Amendment No. 4 to our 2018 Equity Incentive Plan;
4.To authorize the adjournment of the Annual Meeting, if necessary.
|
| 2025-02-13 |
详情>>
业绩披露：
2025年中报每股收益-0.56美元,归母净利润-309.83万美元,同比去年增长-67.01%
|
| 2024-11-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.49美元,归母净利润-196.2万美元,同比去年增长-8795.49%
|
| 2024-09-26 |
复牌提示：
2024-09-26 09:45:37 停牌，复牌日期 2024-09-26 09:50:37
|
| 2024-09-26 |
详情>>
业绩披露：
2024年年报每股收益-4.38美元,归母净利润-1137.71万美元,同比去年增长-20.02%
|
| 2024-05-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.49美元,归母净利润-599.68万美元,同比去年增长-52.84%
|
| 2024-04-24 |
股东大会：
将于2024-06-07召开股东大会
会议内容 ▼▲
- 1.To elect Zhixin Liu, Fu Liu, Yan Yang, Chun Kwok Wong and Michael J. Antonoplos, each to serve until the next annual meeting of stockholders or until their respective successors shall have been elected and qualified;
2.To ratify the appointment of Paris Kreit & Chiu CPA LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024;
3.To approve Amendment No. 3 to our 2018 Equity Incentive Plan;
4.To authorize one or more of our proxy holders to adjourn the Annual Meeting to another time and place, if necessary.
|
| 2024-03-19 |
详情>>
内部人交易：
Liu Fu等共交易16笔
|
| 2024-02-13 |
详情>>
业绩披露：
2024年中报每股收益-0.82美元,归母净利润-185.51万美元,同比去年增长29.42%
|
| 2024-01-18 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2023-11-13 |
详情>>
业绩披露：
2024年一季报每股收益0.00美元,归母净利润-2.21万美元,同比去年增长98.35%
|
| 2023-09-27 |
详情>>
业绩披露：
2023年年报每股收益-0.38美元,归母净利润-947.97万美元,同比去年增长-45.36%
|
| 2023-04-27 |
股东大会：
将于2023-06-20召开股东大会
会议内容 ▼▲
- 1.To elect Zhixin Liu, Fu Liu, Yan Yang, Chun Kwok Wong and Michael J. Antonoplos, each to serve until the next annual meeting of stockholders or until their respective successors shall have been elected and qualified;
2.To ratify the appointment of Paris Kreit & Chiu CPA LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2023;
3.To approve the Amendment No. 2 to our 2018 Equity Incentive Plan;
4.To authorize one or more of our proxy holders to adjourn the Annual Meeting to another time and place, if necessary.
|
| 2022-03-18 |
股东大会：
将于2022-04-28召开股东大会
会议内容 ▼▲
- 1.To elect Zhixin Liu, Fu Liu, Yan Yang, Chun Kwok Wong and Michael J. Antonoplos, each to serve until the next annual meeting of shareholders or until their respective successors shall have been elected and qualified;
2.To ratify the appointment of Paris Kreit & Chiu CPA LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022;
3.To approve the Amendment No.1 to our 2018 Equity Incentive Plan;
4.To transact any other business that is properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-13 |
股东大会：
将于2020-11-16召开股东大会
会议内容 ▼▲
- 1.To elect Zhixin Liu, Fu Liu, Ling Wang, Douglas M. Osrow and Michael James Antonoplos, each to serve until the next annual meeting of shareholders or until their respective successors shall have been elected and qualified;
2.To ratify the appointment of Morison Cogen LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2020;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in this proxy statement;
4.To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers;
5.To transact any other business that is properly brought before the Annual Meeting or any adjournment or postponement thereof.
|